TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | -1 | 1 | 1 | 34 | 80 | 73 | 31 |
| P | %wins | 50 | 50 | 75 | 100 | 100 | 75 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/12 17:13 | 12/20/11 | ECYT | Endocyte Inc | DE | Health | Drug | Pharmaceutical Preparations | Sanderling Ventures Management V | CA | T | P.am | 10 | 3.18 | 1 | 3 | 2 | 183 | I | -6 | 35 | -12 | -3 | 8 | -2 | 1 | -3 | 3 | -2 | 1 | 36 | 4 | ||
1/11/12 17:12 | 12/20/11 | ECYT | Endocyte Inc | DE | Health | Drug | Pharmaceutical Preparations | Sanderling Ventures Management V | CA | T | P.am | 141 | 3.18 | 5 | 44 | 20 | 264 | I | -73 | -65 | -62 | 17 | 5 | 5 | 0 | -2 | 1 | 13 | 120 | 155 | |||
12/22/11 20:29 | 12/20/11 | ECYT | Endocyte Inc | DE | Health | Drug | Pharmaceutical Preparations | Sanderling Ventures Management V | CA | T | P.m | 14 | 3.18 | 4 | 4 | 2 | 184 | I | -74 | -72 | -61 | -70 | -70 | 2 | 2 | 5 | 4 | 63 | 137 | 183 | |||
2/8/11 20:34 | 2/4/11 | ECYT | Endocyte Inc | DE | Health | Drug | Pharmaceutical Preparations | Sanderling Ventures Management V | CA | T | P | 287 | 6.00 | 7 | 48 | 57 | 132 | I | -2 | -2 | 1 | 57 | 26 | -51 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |